The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.

Independent · Updated weekly · 100 compounds

The Compound Report

The research database for peptides, compounds, and longevity interventions.

Browse by goal

100 compounds across 12 categories.

Featured compounds

Fast entry points after you pick a goal — the most-asked-about chapters.

Popular stacks

Community-defined protocols — graded for the combination, not the sum of the parts.

Latest research

Updated weekly. 60 entries from the current corpus.

NewsTirzepatide· 2026-05-15 · 3 weeks ago

SURPASS-CVOT cardiovascular outcomes trial expected to read out Q3 2026 — will define cardiovascular benefit relative to dulaglutide active comparator.

reference-updatePinealon· 2026-05 · 1 month ago

Pinealon split out from the broader Khavinson bioregulator coverage as a standalone compound page with Pinealon-specific evidence boundaries.

New studyTirzepatide· 2026-03-08 · 3 months ago

SYNERGY-NASH publishes: tirzepatide produced MASH resolution in 62% of patients at 52 weeks at top dose, with measurable fibrosis improvement.

Items derive from the most recent citations on each compound chapter until the live aggregator ships.

We document peer-reviewed science and community reality in parallel — visibly distinct, never blended.

How we work